Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients
E Tuaillon, K Bolloré, A Pisoni, S Debiesse, C Renault, S Marie, S Groc, C Niels, N Pansu, AM Dupuy, D Morquin, V Foulongne, A Bourdin, V Le Moing, P Van de Perre
doi: https://doi.org/10.1101/2020.05.04.20090027
E Tuaillon
1Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS; CHU Montpellier, Montpellier, France
K Bolloré
2Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS, Montpellier, France
A Pisoni
1Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS; CHU Montpellier, Montpellier, France
S Debiesse
2Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS, Montpellier, France
C Renault
2Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS, Montpellier, France
S Marie
3Montpellier University Hospital, Montpellier, France
S Groc
3Montpellier University Hospital, Montpellier, France
C Niels
3Montpellier University Hospital, Montpellier, France
N Pansu
3Montpellier University Hospital, Montpellier, France
AM Dupuy
3Montpellier University Hospital, Montpellier, France
D Morquin
3Montpellier University Hospital, Montpellier, France
V Foulongne
1Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS; CHU Montpellier, Montpellier, France
A Bourdin
3Montpellier University Hospital, Montpellier, France
V Le Moing
3Montpellier University Hospital, Montpellier, France
P Van de Perre
1Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS; CHU Montpellier, Montpellier, France

Article usage
Posted May 27, 2020.
Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients
E Tuaillon, K Bolloré, A Pisoni, S Debiesse, C Renault, S Marie, S Groc, C Niels, N Pansu, AM Dupuy, D Morquin, V Foulongne, A Bourdin, V Le Moing, P Van de Perre
medRxiv 2020.05.04.20090027; doi: https://doi.org/10.1101/2020.05.04.20090027
Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients
E Tuaillon, K Bolloré, A Pisoni, S Debiesse, C Renault, S Marie, S Groc, C Niels, N Pansu, AM Dupuy, D Morquin, V Foulongne, A Bourdin, V Le Moing, P Van de Perre
medRxiv 2020.05.04.20090027; doi: https://doi.org/10.1101/2020.05.04.20090027
Subject Area
Subject Areas
- Addiction Medicine (423)
- Allergy and Immunology (746)
- Anesthesia (219)
- Cardiovascular Medicine (3240)
- Dermatology (271)
- Emergency Medicine (476)
- Epidemiology (13260)
- Forensic Medicine (19)
- Gastroenterology (892)
- Genetic and Genomic Medicine (5072)
- Geriatric Medicine (471)
- Health Economics (774)
- Health Informatics (3199)
- Health Policy (1130)
- Hematology (423)
- HIV/AIDS (1005)
- Medical Education (468)
- Medical Ethics (126)
- Nephrology (515)
- Neurology (4829)
- Nursing (255)
- Nutrition (717)
- Oncology (2490)
- Ophthalmology (706)
- Orthopedics (279)
- Otolaryngology (338)
- Pain Medicine (321)
- Palliative Medicine (89)
- Pathology (533)
- Pediatrics (1283)
- Primary Care Research (551)
- Public and Global Health (7391)
- Radiology and Imaging (1676)
- Respiratory Medicine (974)
- Rheumatology (474)
- Sports Medicine (417)
- Surgery (535)
- Toxicology (69)
- Transplantation (233)
- Urology (202)